DR. KEEGAN ANTHONY HARKINS M.D.
Prescription History 1053758136
Ophthalmology in Omaha, NE


Quality Rating: 80.1 out of 100 score

NPI Status: Active since May 29, 2013

Contact Information

3902 LEAVENWORTH ST
OMAHA, NE
ZIP 68105
Phone: (402) 559-2020

Get Directions

Prescription History for Informed Healthcare Decisions

Explore the verified Medicare Part D prescription history, volume metrics, and calculated drug costs for DR. KEEGAN ANTHONY HARKINS M.D., an active Ophthalmology specialist practicing in Omaha, NE. Our medical registry currently tracks 19 unique pharmaceutical formulations prescribed by this provider, representing an estimated volume of 2,036 documented patient claims. Among these therapy options, the most frequently utilized medication is Latanoprost, which accounts for 576 claims alone.


Alphagan P

Generic Formulation: Brimonidine TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 27
30-Day Fills 27.0
Days Supply 675
NE State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills41.1
Peer Average Days Supply1,163
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,616.31 across this reporting matrix range.

Provider Avg Cost Per Claim

$208.01

State Avg Cost Per Claim

$340.72

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Brimonidine Tartrate

Generic Formulation: Brimonidine TartrateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 171
30-Day Fills 219.6
Days Supply 5,558
NE State Average Benchmarks
Peer Average Claims51.0
Peer Average 30-Day Fills82.6
Peer Average Days Supply2,347
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 235.3% higher than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,963.44 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.03

State Avg Cost Per Claim

$29.63

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A quinoxaline derivative and ADRENERGIC ALHPA-2 RECEPTOR AGONIST that is used to manage INTRAOCULAR PRESSURE associated with OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

This medication is used to treat open-angle glaucoma or high fluid pressure in the eye. Lowering high fluid pressure in the eye reduces the risk of vision loss, nerve damage, or blindness. This medication lowers pressure by allowing better fluid drainage from within the eye and also by reducing the amount of fluid formed in the eye. It is known as an alpha agonist. This drug is not recommended for use in children less than 2 years of age due to an increased risk of serious side effects such as very slowed breathing. Ask the doctor or pharmacist for details.

Combigan

Generic Formulation: Brimonidine Tartrate/TimololSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 24
30-Day Fills 26.1
Days Supply 655
NE State Average Benchmarks
Peer Average Claims32.0
Peer Average 30-Day Fills47.2
Peer Average Days Supply1,327
Standard Average Utilization

This provider's prescribing patterns for this therapeutic formulation sit directly in line with standard baseline averages across NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,496.24 across this reporting matrix range.

Provider Avg Cost Per Claim

$229.01

State Avg Cost Per Claim

$330.11

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pharmaceutical preparation of brimonidine tartrate and timolol maleate. The combined ADRENERGIC ALPHA2 RECEPTOR AGONIST and ADRENERGIC BETA-ANTAGONIST activity of these drugs reduce INTRAOCULAR PRESSURE in GLAUCOMA patients.

Therapeutic Applications

This combination medication is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This product contains brimonidine and timolol. These medications are used together when 1 drug is not controlling the pressure inside the eye. Brimonidine works by allowing better fluid drainage from within the eye and also by decreasing the amount of fluid formed in the eye. It belongs to a class of drugs known as alpha agonists. Timolol is thought to work by decreasing the amount of fluid formed in the eye. Timolol belongs to a class of drugs known as beta blockers. This medication is not recommended for use in children less than 2 years old due to an increased risk of serious side effects. Ask the doctor or pharmacist for more details.

Difluprednate

Generic Formulation: DifluprednateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 15
30-Day Fills 15.9
Days Supply 400
NE State Average Benchmarks
Peer Average Claims28.0
Peer Average 30-Day Fills30.8
Peer Average Days Supply713
Conservative Utilization

This provider writes prescriptions for this formulation 46.4% less frequently than the standard regional baseline metric for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,270.49 across this reporting matrix range.

Provider Avg Cost Per Claim

$151.37

State Avg Cost Per Claim

$162.24

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat swelling and pain after eye surgery. It may also be used to treat a certain serious eye problem (endogenous anterior uveitis). This medication belongs to a class of drugs known as corticosteroids.

Dorzolamide Hcl

Generic Formulation: Dorzolamide HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 81
30-Day Fills 122.2
Days Supply 3,639
NE State Average Benchmarks
Peer Average Claims42.0
Peer Average 30-Day Fills76.8
Peer Average Days Supply2,295
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 92.9% higher than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $1,563.57 across this reporting matrix range.

Provider Avg Cost Per Claim

$19.30

State Avg Cost Per Claim

$27.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Dorzolamide is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. It belongs to a class of drugs known as carbonic anhydrase inhibitors.

Dorzolamide-Timolol

Generic Formulation: Dorzolamide Hcl/Timolol MaleatSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 149
30-Day Fills 281.5
Days Supply 8,438
NE State Average Benchmarks
Peer Average Claims76.0
Peer Average 30-Day Fills149.6
Peer Average Days Supply4,470
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 96.1% higher than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,751.03 across this reporting matrix range.

Provider Avg Cost Per Claim

$18.46

State Avg Cost Per Claim

$27.32

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This product contains two drugs used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers, and dorzolamide belongs to a class of drugs known as carbonic anhydrase inhibitors.

Doxycycline Hyclate

Generic Formulation: Doxycycline HyclateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 11
30-Day Fills 11.0
Days Supply 285
NE State Average Benchmarks
Peer Average Claims27.0
Peer Average 30-Day Fills29.4
Peer Average Days Supply428
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 59.3% less volume than the regional standard for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $249.72 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.70

State Avg Cost Per Claim

$26.13

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A synthetic tetracycline derivative with similar antimicrobial activity.

Therapeutic Applications

This medication is used to treat a wide variety of bacterial infections, including those that cause acne. This medication is also used to prevent malaria. This medication is known as a tetracycline antibiotic. It works by stopping the growth of bacteria. This antibiotic treats only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Erythromycin

Generic Formulation: Erythromycin BaseSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 19
30-Day Fills 19.0
Days Supply 256
NE State Average Benchmarks
Peer Average Claims36.0
Peer Average 30-Day Fills36.9
Peer Average Days Supply496
Conservative Utilization

This provider writes prescriptions for this formulation 47.2% less frequently than the standard regional baseline metric for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $220.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$11.60

State Avg Cost Per Claim

$20.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Erythromycin is used to treat a wide variety of bacterial infections. It may also be used to prevent certain bacterial infections. Erythromycin is known as a macrolide antibiotic. It works by stopping the growth of bacteria. This antibiotic treats or prevents only bacterial infections. It will not work for viral infections (such as common cold, flu). Using any antibiotic when it is not needed can cause it to not work for future infections.

Gentamicin Sulfate

Generic Formulation: Gentamicin SulfateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 12
30-Day Fills 12.0
Days Supply 234
NE State Average Benchmarks
Peer Average Claims17.0
Peer Average 30-Day Fills17.6
Peer Average Days Supply346
Conservative Utilization

This provider writes prescriptions for this formulation 29.4% less frequently than the standard regional baseline metric for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $152.65 across this reporting matrix range.

Provider Avg Cost Per Claim

$12.72

State Avg Cost Per Claim

$39.66

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A complex of closely related aminoglycosides obtained from MICROMONOSPORA purpurea and related species. They are broad-spectrum antibiotics, but may cause ear and kidney damage. They act to inhibit PROTEIN BIOSYNTHESIS.

Therapeutic Applications

This medication is used to treat bacterial infections (such as blepharitis, conjunctivitis) of the eye and the skin around the eyes (such as eyelids). It is also used to prevent infection after eye injury or surgery. It belongs to a class of drugs known as aminoglycoside antibiotics. Gentamicin works by killing the bacteria. This medication treats only bacterial eye infections. It will not work for other types of eye infections. Unnecessary use or misuse of any antibiotic can lead to its decreased effectiveness. This drug should not be used in newborns due to an increased risk of serious side effects.

Ketorolac Tromethamine

Generic Formulation: Ketorolac TromethamineSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 188
30-Day Fills 189.5
Days Supply 3,843
NE State Average Benchmarks
Peer Average Claims77.0
Peer Average 30-Day Fills85.1
Peer Average Days Supply1,937
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 144.2% higher than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $4,150.99 across this reporting matrix range.

Provider Avg Cost Per Claim

$22.08

State Avg Cost Per Claim

$24.37

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is a non-steroidal anti-inflammatory agent used for analgesia for postoperative pain and inhibits cyclooxygenase activity.

Therapeutic Applications

This medication is used to temporarily relieve itching eyes caused by seasonal allergies. It is also used to prevent and treat eye swelling due to a certain type of eye surgery (cataract removal). Ketorolac belongs to a class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs). It works by blocking certain natural substances in your body to reduce pain and swelling.

Latanoprost

Generic Formulation: LatanoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 576
30-Day Fills 874.4
Days Supply 24,389
NE State Average Benchmarks
Peer Average Claims121.0
Peer Average 30-Day Fills192.8
Peer Average Days Supply5,441
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 376.0% higher than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,492.69 across this reporting matrix range.

Provider Avg Cost Per Claim

$14.74

State Avg Cost Per Claim

$19.95

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A prostaglandin F analog used to treat OCULAR HYPERTENSION in patients with GLAUCOMA.

Therapeutic Applications

Latanoprost is used to treat high pressure inside the eye due to glaucoma (open angle type) or other eye diseases (such as ocular hypertension). It is similar to a natural chemical in the body (prostaglandin) and works by regulating the flow of fluid within the eye which results in lower pressure. Lowering high pressure inside the eye helps to prevent blindness.

Lumigan

Generic Formulation: BimatoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 22
30-Day Fills 24.8
Days Supply 679
NE State Average Benchmarks
Peer Average Claims43.0
Peer Average 30-Day Fills67.4
Peer Average Days Supply1,917
Conservative Utilization

This provider writes prescriptions for this formulation 48.8% less frequently than the standard regional baseline metric for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $6,259.79 across this reporting matrix range.

Provider Avg Cost Per Claim

$284.54

State Avg Cost Per Claim

$400.80

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cloprostenol-derived amide that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

Bimatoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Moxifloxacin

Generic Formulation: Moxifloxacin HclSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 172
30-Day Fills 172.0
Days Supply 2,284
NE State Average Benchmarks
Peer Average Claims128.0
Peer Average 30-Day Fills130.0
Peer Average Days Supply1,872
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 34.4% more claims than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $5,004.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$29.10

State Avg Cost Per Claim

$36.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A fluoroquinolone that acts as an inhibitor of DNA TOPOISOMERASE II and is used as a broad-spectrum antibacterial agent.

Therapeutic Applications

This medication is a quinolone antibiotic used for eye infections.

Neomycin-Polymyxin-Dexameth

Generic Formulation: Neomycin/Polymyxin B/DexamethaSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 17
30-Day Fills 17.3
Days Supply 294
NE State Average Benchmarks
Peer Average Claims31.0
Peer Average 30-Day Fills32.1
Peer Average Days Supply486
Conservative Utilization

This provider writes prescriptions for this formulation 45.2% less frequently than the standard regional baseline metric for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $303.85 across this reporting matrix range.

Provider Avg Cost Per Claim

$17.87

State Avg Cost Per Claim

$14.42

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat conditions involving swelling (inflammation) of the eyes and to treat or prevent bacterial eye infections. This product contains neomycin and polymyxin, antibiotics that work by stopping the growth of bacteria. It also contains dexamethasone, an anti-inflammatory corticosteroid that works by reducing swelling. This medication treats/prevents only bacterial eye infections. It will not work for other types of eye infections and may worsen them (such as infections caused by viruses, fungi, mycobacteria). Unnecessary use or overuse of any antibiotic can lead to its decreased effectiveness.

Prednisolone Acetate

Generic Formulation: Prednisolone AcetateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 244
30-Day Fills 257.8
Days Supply 5,410
NE State Average Benchmarks
Peer Average Claims94.0
Peer Average 30-Day Fills118.9
Peer Average Days Supply2,995
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 159.6% higher than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $8,456.16 across this reporting matrix range.

Provider Avg Cost Per Claim

$34.66

State Avg Cost Per Claim

$52.22

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

This medication is used to treat certain eye conditions due to inflammation or injury. Prednisolone works by relieving symptoms such as swelling, redness, and itching. It belongs to a class of drugs known as corticosteroids.

Restasis

Generic Formulation: CyclosporineSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 12
30-Day Fills 14.5
Days Supply 435
NE State Average Benchmarks
Peer Average Claims29.0
Peer Average 30-Day Fills42.0
Peer Average Days Supply1,183
Highly Conservative Utilization

This provider demonstrates a highly selective approach to this formula, recording 58.6% less volume than the regional standard for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,928.32 across this reporting matrix range.

Provider Avg Cost Per Claim

$827.36

State Avg Cost Per Claim

$898.21

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection.

Therapeutic Applications

Cyclosporine eye drops are used to treat a certain type of dry eyes. They work by increasing the amount of tears you make.

Rhopressa

Generic Formulation: Netarsudil MesylateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 24
30-Day Fills 30.3
Days Supply 812
NE State Average Benchmarks
Peer Average Claims45.0
Peer Average 30-Day Fills65.4
Peer Average Days Supply1,816
Conservative Utilization

This provider writes prescriptions for this formulation 46.7% less frequently than the standard regional baseline metric for practitioners inside NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $9,369.88 across this reporting matrix range.

Provider Avg Cost Per Claim

$390.41

State Avg Cost Per Claim

$420.94

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Therapeutic Applications

Netarsudil is used to treat high pressure inside the eye due to certain eye conditions (such as open-angle glaucoma, ocular hypertension). This medication is thought to work by increasing the flow of fluid out of the eye. This helps lower pressure inside the eye. Lowering high pressure inside the eye can help prevent loss of vision or blindness.

Timolol Maleate

Generic Formulation: Timolol MaleateSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 239
30-Day Fills 448.9
Days Supply 13,204
NE State Average Benchmarks
Peer Average Claims58.0
Peer Average 30-Day Fills112.0
Peer Average Days Supply3,301
Highly Elevated Utilization

This provider exhibits a high preference for this treatment path, registering a volume 312.1% higher than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $2,530.52 across this reporting matrix range.

Provider Avg Cost Per Claim

$10.59

State Avg Cost Per Claim

$16.57

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A beta-adrenergic antagonist that is similar in action to PROPRANOLOL; the levo-isomer is more active. Timolol has been proposed as an anti-hypertensive, anti-arrhythmic, anti-angina, and anti-glaucoma agent. It is also used in the treatment of MIGRAINE DISORDERS and tremor.

Therapeutic Applications

This medication is used to treat high pressure inside the eye due to glaucoma (open angle-type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye helps to prevent blindness. This medication works by decreasing the amount of fluid within the eye. Timolol belongs to a class of drugs known as beta-blockers.

Travoprost

Generic Formulation: TravoprostSpecialty: Ophthalmology
Provider Metrics Summary
Total Claims 33
30-Day Fills 39.7
Days Supply 984
NE State Average Benchmarks
Peer Average Claims23.0
Peer Average 30-Day Fills33.6
Peer Average Days Supply946
Elevated Utilization

This provider maintains an active emphasis on this therapeutic option, recording 43.5% more claims than the standard regional baseline profile for NE. Gross expenditures recorded under Medicare program tracking definitions for this provider calculate to an estimated aggregate of $3,761.26 across this reporting matrix range.

Provider Avg Cost Per Claim

$113.98

State Avg Cost Per Claim

$182.68

Note on Expenses: These indicators represent gross infrastructure resource tracking paid directly to supply pharmacy networks by Medicare Part D configurations. These calculations do not track individual patient insurance tier copays or out-of-pocket shelf prices at retail checkout lanes.

Clinical Summary

A cloprostenol derivative that is used as an ANTIHYPERTENSIVE AGENT in the treatment of OPEN-ANGLE GLAUCOMA and OCULAR HYPERTENSION.

Therapeutic Applications

Travoprost is used to treat high pressure inside the eye due to glaucoma (open-angle type) or other eye diseases (such as ocular hypertension). Lowering high pressure inside the eye can help prevent blindness. This medication works by regulating the flow of fluid within the eye to maintain a normal pressure.

Dataset Methodology & CMS Source Information

This analytical profile maps public infrastructure records sourced directly from official **Centers for Medicare & Medicaid Services (CMS)** public data releases. The statistics above track documented pharmaceutical treatment trends assigned to beneficiaries specifically under federal public programs. Evaluating the prescriptive footprints of clinical practitioners like DR. KEEGAN ANTHONY HARKINS M.D. provides transparency into local medical care patterns within Omaha, NE.

Key Learning Objectives for this Profile:

  • Prescribing Frequencies: Track and evaluate the volume metrics of specific brand-name and generic medical formulas chosen by this provider over time.
  • Clinical Focus Areas: Identify how the provider distributes therapeutic selections across medical care options to gain insight into their true day-to-day **Ophthalmology** practice concentrations.
  • Program Cost Awareness: Review the calculated total systemic drug costs and raw transactional volumes linked to these orders to better anticipate network insurance coverage structures.
  • Patient-Centered Evaluation: Cross-reference localized regional care comparisons to align practitioner habits directly with your proactive health maintenance goals.

Data Scope Exclusion & Limitations: The data elements presented above explicitly reflect prescription orders processed for Medicare beneficiaries during the year 2023. This informational profile does not aggregate prescription data for individuals utilizing private commercial health plans, state Medicaid coverage, or self-pay options. However, because medical decision-making remains highly consistent across clinical settings, this public registry provides a reliable proxy for understanding the general prescribing preferences and pharmaceutical care approach used by this provider.